Ernexa Therapeutics Inc.: 10-Q filed 2011-08-12
What Ernexa Therapeutics Inc. reported in its quarterly report filed 2011-08-12 (fiscal Q2 2011): 28 published measures, 71 facts as tagged in accession 0001019687-11-002572.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-08-12
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001019687-11-002572 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ernexa Therapeutics Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 12,874,000 | USD | |
| At 2010-12-31 | 13,125,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 4,753,000 | USD | |
| At 2010-12-31 | 3,664,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 8,121,000 | USD | |
| At 2010-12-31 | 9,461,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 3,085,000 | USD | |
| At 2010-12-31 | 3,906,000 | USD | |
| At 2010-06-30 | 3,268,000 | USD | |
| At 2009-12-31 | 3,637,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -984,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,543,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -457,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -846,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 819,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 868,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -1,430,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -1,090,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -108,835,000 | USD | |
| At 2010-12-31 | -107,284,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 60,388 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 60,387 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 60,188 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 60,045 | shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 11,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -13,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 23,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 4,319,000 | USD | |
| At 2010-12-31 | 3,638,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 154,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 156,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -1,053,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,573,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -407,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -766,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 4,140,000 | USD | |
| At 2010-12-31 | 5,227,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 3,920,000 | USD | |
| At 2010-12-31 | 3,336,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 1,291,000 | USD | |
| At 2010-12-31 | 1,261,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 827,000 | USD | |
| At 2010-12-31 | 1,025,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 475,000 | USD | |
| At 2010-12-31 | 549,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 6,946,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 13,467,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 6,598,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 13,228,000 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 5,374,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 10,206,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 4,898,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 9,816,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 60,892 | shares | |
| At 2010-12-31 | 60,751 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 797,000 | USD | |
| At 2010-12-31 | 782,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 89,000 | USD | |
| At 2010-12-31 | 41,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 31,000 | USD | |
| At 2010-12-31 | 99,000 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 1,588,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 1,599,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 69,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 41,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -63,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -57,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 28,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 50,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 93,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -99,000 | USD | 181 |
Inspect the source
- Entity
- Ernexa Therapeutics Inc. / CIK 0000748592
- Captured
- 2026-09-19T15:01:44.435Z
- SEC response SHA-256
c12754d65dfa742127976ccd7c75bc4379d46dc7b617393cfbda0b7763329d5c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000748592.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))